A detailed history of White Pine Capital LLC transactions in Axogen, Inc. stock. As of the latest transaction made, White Pine Capital LLC holds 121,382 shares of AXGN stock, worth $1.53 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
121,382
Previous 116,312 4.36%
Holding current value
$1.53 Million
Previous $842,000 102.02%
% of portfolio
0.6%
Previous 0.33%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.52 - $14.69 $38,126 - $74,478
5,070 Added 4.36%
121,382 $1.7 Million
Q2 2024

Aug 13, 2024

BUY
$5.67 - $8.06 $29,308 - $41,662
5,169 Added 4.65%
116,312 $842,000
Q1 2024

May 13, 2024

BUY
$6.63 - $10.69 $22,608 - $36,452
3,410 Added 3.17%
111,143 $896,000
Q4 2023

Feb 02, 2024

BUY
$3.61 - $7.76 $217,683 - $467,928
60,300 Added 127.13%
107,733 $735,000
Q3 2023

Nov 09, 2023

SELL
$4.68 - $9.26 $216,946 - $429,256
-46,356 Reduced 49.43%
47,433 $237,000
Q2 2023

Aug 08, 2023

SELL
$8.5 - $10.38 $3,187 - $3,892
-375 Reduced 0.4%
93,789 $856,000
Q1 2023

May 09, 2023

SELL
$7.53 - $10.95 $4,947 - $7,194
-657 Reduced 0.69%
94,164 $889,000
Q4 2022

Feb 10, 2023

BUY
$9.44 - $13.09 $6,277 - $8,704
665 Added 0.71%
94,821 $946,000
Q3 2022

Nov 08, 2022

BUY
$8.14 - $12.25 $595,237 - $895,781
73,125 Added 347.7%
94,156 $1.12 Million
Q2 2022

Aug 16, 2022

SELL
$6.99 - $10.0 $50,104 - $71,680
-7,168 Reduced 25.42%
21,031 $172,000
Q1 2022

May 12, 2022

BUY
$7.26 - $10.7 $110,526 - $162,896
15,224 Added 117.33%
28,199 $224,000
Q4 2021

Feb 11, 2022

BUY
$8.8 - $16.0 $114,180 - $207,600
12,975 New
12,975 $122,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track White Pine Capital LLC Portfolio

Follow White Pine Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Pine Capital LLC with notifications on news.